Trial Profile
Comparision of perioperative bleeding complications and mid-term outcomes of recieving ticagrelor or clopidogrel in patients with acute coronary syndrome (ACS) undergoing coronary artery bypass grafting (CABG)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jan 2017
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association